Skip to main content
InnovAge Holding Corp. (INNV)
NASDAQ: INNV · Real-Time Price · USD
4.190
+0.660 (18.70%)
Dec 20, 2024, 4:00 PM EST - Market closed

InnovAge Holding Revenue

InnovAge Holding had revenue of $205.14M in the quarter ending September 30, 2024, with 12.42% growth. This brings the company's revenue in the last twelve months to $786.51M, up 12.46% year-over-year. In the fiscal year ending June 30, 2024, InnovAge Holding had annual revenue of $763.86M with 11.01% growth.

Revenue (ttm)
$786.51M
Revenue Growth
+12.46%
P/S Ratio
0.72
Revenue / Employee
$334,686
Employees
2,350
Market Cap
567.56M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 2024763.86M75.77M11.01%
Jun 30, 2023688.09M-10.55M-1.51%
Jun 30, 2022698.64M60.84M9.54%
Jun 30, 2021637.80M70.61M12.45%
Jun 30, 2020567.19M101.56M21.81%
Jun 30, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Xeris Biopharma Holdings 187.36M
Talkspace 181.29M
Sangamo Therapeutics 52.29M
EyePoint Pharmaceuticals 45.71M
Phathom Pharmaceuticals 26.27M
CorMedix 12.26M
Mereo BioPharma Group 1.00M
Opthea 261.86K
Revenue Rankings

INNV News

More News